Olathe biotech moves dog cancer treatment closer to market

UTC
US NEWS FEEDS > MISSOURI > KANSAS CITY >

A Kansas City-area animal health company is ramping up its efforts to take its cancer immunotherapy treatment to market. Elias Animal Health, a subsidiary of Olathe-based TVAX Biomedical Inc., applied for a conditional licensure of its treatment for dogs with bone cancer through the U.S. Department of Agriculture’s Center for Veterinary Biologics. Elias recently completed preliminary studies of its osteosarcoma treatment and will enroll for a pivotal study as the next step. On Thursday, the…
...
News Feed:
Kansas City Business News - Local Kansas City News | Kansas City Business Journal

READ MORE >
Olathe biotech moves dog cancer treatment closer to market

Sponsored Content